Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 2:43 PM
Ignite Modification Date:
2025-12-26 @ 2:43 PM
NCT ID:
NCT07237906
Eligibility Criteria:
Inclusion Criteria:
* Initiation of TNF-alpha inhibitor therapy at least once in our clinic between September 2023 and January 2025
* Age 18 years or older
* At least one complete blood count performed during the follow-up period
* Availability of complete clinical and laboratory data in the hospital's electronic medical records or patient files
Exclusion Criteria:
* History of other hematologic disorders that may contribute to the development of neutropenia (e.g., aplastic anemia, leukemia, myelodysplastic syndrome)
* Concurrent treatment with cytotoxic chemotherapy or immunosuppressive agents (e.g., azathioprine, cyclophosphamide)
* Insufficient follow-up duration or incomplete laboratory data that precluded adequate evaluation
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07237906
Study Brief:
Protocol Section:
NCT07237906